The expression of eIF4G1 was also higher in the serous ovarian cancer specimens (GSE18521: P<0.0001; GSE40595: P = 0.0028) as shown in Fig 1B and 1C. This evidence concerns the gene EIF4G1 and ovarian serous adenocarcinoma.